Mark Muldoon

Mark Muldoon

Auto-generated profile, based on publicly available information

Mark Muldoon

Department of Mathematics, University of Manchester, Oxford Road, Manchester, M13 9PL, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2000 in Science
Verified
Journal Article
Open access
PDF file
BKBette Tina Marie Korber
Bette Tina Marie Korber
MMM. Muldoon
M. Muldoon
JTJ. Theiler
J. Theiler
FGF. Gao
F. Gao
RGR. Gupta
R. Gupta
TBT. Bhattacharya
T. Bhattacharya
HIV-1 sequences were analyzed to estimate the timing of the ancestral sequence of the main group of HIV-1, the strains responsible for the AIDS pandemic. Using parallel supercomputers and assuming a constant rate of evolution, we applied maximum-likelihood phylogenetic methods to unprecedented amounts of data for this calculation. We validated our approach by correctly estimating the timing of two historically documented points. Using a comprehensive full-length envelope sequence alignment, we estimated the date of the last common ancestor of the main group of HIV-1 to be 1931 (1915–41). Analysis of a gag gene alignment, subregions of envelope including additional sequences, and a method that relaxed the assumption of a strict molecular clock also supported these results.

26 March 2004 in Science
Verified
Journal Article
Closed access
PDF file
CDCynthia A. Derdeyn
Cynthia A. Derdeyn
JDJulie M. Decker
Julie M. Decker
FBFrederic Bibollet-Ruche
Frederic Bibollet-Ruche
JMJohn L. Mokili
John L. Mokili
MMMark Muldoon
Mark Muldoon
EHEric Hunter
Eric Hunter
Heterosexual transmission accounts for the majority of human immunodeficiency virus–1 (HIV-1) infections worldwide, yet the viral properties that determine transmission fitness or outgrowth have not been elucidated. Here we show, for eight heterosexual transmission pairs, that recipient viruses were monophyletic, encoding compact, glycan-restricted envelope glycoproteins. These viruses were also uniquely sensitive to neutralization by antibody from the transmitting partner. Thus, the exposure of neutralizing epitopes, which are lost in chronic infection because of immune escape, appears to be favored in the newly infected host. This reveals characteristics of the envelope glycoprotein that influence HIV-1 transmission and may have implications for vaccine design.

29 March 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NPNicholas F. Parrish
Nicholas F. Parrish
FGFeng Gao
Feng Gao
HLHui Li
Hui Li
EGElena E. Giorgi
Elena E. Giorgi
HBHannah J. Barbian
Hannah J. Barbian
BHBeatrice Hahn
Beatrice Hahn
Defining the virus–host interactions responsible for HIV-1 transmission, including the phenotypic requirements of viruses capable of establishing de novo infections, could be important for AIDS vaccine development. Previous analyses have failed to identify phenotypic properties other than chemokine receptor 5 (CCR5) and CD4+ T-cell tropism that are preferentially associated with viral transmission. However, most of these studies were limited to examining envelope (Env) function in the context of pseudoviruses. Here, we generated infectious molecular clones of transmitted founder (TF; n = 27) and chronic control (CC; n = 14) viruses of subtypes B ( n = 18) and C ( n = 23) and compared their phenotypic properties in assays specifically designed to probe the earliest stages of HIV-1 infection. We found that TF virions were 1.7-fold more infectious ( P = 0.049) and contained 1.9-fold more Env per particle ( P = 0.048) compared with CC viruses. TF viruses were also captured by monocyte-derived dendritic cells 1.7-fold more efficiently ( P = 0.035) and more readily transferred to CD4+ T cells ( P = 0.025). In primary CD4+ T cells, TF and CC viruses replicated with comparable kinetics; however, when propagated in the presence of IFN-α, TF viruses replicated to higher titers than CC viruses. This difference was significant for subtype B ( P = 0.000013) but not subtype C ( P = 0.53) viruses, possibly reflecting demographic differences of the respective patient cohorts. Together, these data indicate that TF viruses are enriched for higher Env content, enhanced cell-free infectivity, improved dendritic cell interaction, and relative IFN-α resistance. These viral properties, which likely act in concert, should be considered in the development and testing of AIDS vaccines.

21 February 2010 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DBDan H. Barouch
Dan H. Barouch
KOKara L O'BRien
Kara L O'BRien
NSNathaniel L Simmons
Nathaniel L Simmons
SKSharon L King
Sharon L King
PAPeter Abbink
Peter Abbink
BKBette Tina Marie Korber
Bette Tina Marie Korber
Vaccine design is challenging when the infectious agent is genetically diverse. Polyvalent 'mosaic' antigens might be used to address this challenge, and these two studies show promising results in monkeys infected with HIV-1 ( pages 268–270 and 324–328 ). The worldwide diversity of HIV-1 presents an unprecedented challenge for vaccine development1,2. Antigens derived from natural HIV-1 sequences have elicited only a limited breadth of cellular immune responses in nonhuman primate studies and clinical trials to date. Polyvalent 'mosaic' antigens, in contrast, are designed to optimize cellular immunologic coverage of global HIV-1 sequence diversity3. Here we show that mosaic HIV-1 Gag, Pol and Env antigens expressed by recombinant, replication-incompetent adenovirus serotype 26 vectors markedly augmented both the breadth and depth without compromising the magnitude of antigen-specific T lymphocyte responses as compared with consensus or natural sequence HIV-1 antigens in rhesus monkeys. Polyvalent mosaic antigens therefore represent a promising strategy to expand cellular immunologic vaccine coverage for genetically diverse pathogens such as HIV-1.

21 February 2010 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SSSampa Santra
Sampa Santra
HLHua-Xin Liao
Hua-Xin Liao
RZRuijin Zhang
Ruijin Zhang
MMMark Muldoon
Mark Muldoon
SWSydeaka Watson
Sydeaka Watson
NLNorman L Letvin
Norman L Letvin
Vaccine design is challenging when the infectious agent is genetically diverse. Polyvalent 'mosaic' antigens might be used to address this challenge, and these two studies show promising results in monkeys infected with HIV-1 ( pages 268–270 and pages 319–323 ). An effective HIV vaccine must elicit immune responses that recognize genetically diverse viruses1,2. It must generate CD8+ T lymphocytes that control HIV replication and CD4+ T lymphocytes that provide help for the generation and maintenance of both cellular and humoral immune responses against the virus3,4,5. Creating immunogens that can elicit cellular immune responses against the genetically varied circulating isolates of HIV presents a key challenge for creating an HIV vaccine6,7. Polyvalent mosaic immunogens derived by in silico recombination of natural strains of HIV are designed to induce cellular immune responses that recognize genetically diverse circulating virus isolates8. Here we immunized rhesus monkeys by plasmid DNA prime and recombinant vaccinia virus boost with vaccine constructs expressing either consensus or polyvalent mosaic proteins. As compared to consensus immunogens, the mosaic immunogens elicited CD8+ T lymphocyte responses to more epitopes of each viral protein than did the consensus immunogens and to more variant sequences of CD8+ T lymphocyte epitopes. This increased breadth and depth of epitope recognition may contribute both to protection against infection by genetically diverse viruses and to the control of variant viruses that emerge as they mutate away from recognition by cytotoxic T lymphocytes.

22 December 2003 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
KBKarine Berthelot
Karine Berthelot
MMMark Muldoon
Mark Muldoon
LRLukas Rajkowitsch
Lukas Rajkowitsch
JHJohn Hughes
John Hughes
JMJohn E. G. McCarthy
John E. G. McCarthy
Summary: The eukaryotic 40S ribosomal subunit locates the translation initiation codon on an mRNA via the so‐called scanning process that follows 40S binding to the capped 5′ end. This key step in translation is required for the expression of almost all eukaryotic genes, yet the mechanism and dynamics of scanning are unknown. We have performed quantitative studies in vivo and in vitro of the movement of yeast 40S ribosomes along 5′ untranslated regions (UTRs) of different lengths. 40S subunits perform cap‐dependent scanning with high processivity for more than 1700 nucleotides in cells of Saccharomyces cerevisiae. Moreover, the observed rates of expression indicate that scanning is performed by an untethered 40S subunit that has been released from the 5′ cap complex. Unexpectedly, the capability to maintain scanning competence on a long 5′ UTR is more dependent on the Ded1/Dbp1 type of helicase than on eIF4A or eIF4B. In a yeast cell‐free extract, scanning shows reduced processivity, with an estimated net 5′→3′ rate of approximately 10 nucleotides per second at 26°C. We have developed a biased bidirectional walking model of ribosomal scanning that provides a framework for understanding the above observations as well as other known quantitative and qualitative features of this process.